Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 16 Jun, 01:34 am
Analyst Rating: Morgan Stanley initiated coverage with an "Overweight" rating and a $371 price target for Onto Innovation Inc. Strong Performance & Growth Drivers: The stock has gained over 174% in the past year, fueled by robust demand for AI infrastructure and advanced semicond
Analyst initiates "Buy" rating for Vista Energy (NYSE:VIST) with a $95.00 price target, suggesting significant upside. Vista Energy is considered undervalued by GuruFocus, with a GF Value of $78.39 and a strong GF Score of 84 out of 100 . Institutional investors, like Baron Emerg
CME Group is expanding its 24/7 global derivatives trading services with new micro WTI crude oil and 1-Ounce Gold futures contracts, pending regulatory approval. This strategic expansion addresses growing demand for flexible investment risk management tools, supported by robust t
Revenue Miss: Roots (OTC: RROTF) 's Q1 2026 revenue of $31.32 million fell short of analyst estimates, despite underlying sales growth in Canadian dollars. Profitability Decline: The company reported an earnings per share of -$0.14 , below expectations, primarily due to a decline
Q2 Performance: Coffee Holding Co., Inc. reported an earnings per share (EPS) of $0.05 , missing analyst estimates of $0.08 , with revenue also falling short at $22.13 million against an estimated $24.60 million . Market Impact: The decline in revenue was primarily driven by a 5.
ABM Industries (NYSE): CEO Sells Shares Amidst Strong Q2 Revenue Growth and Mixed Earnings CEO Scott B. Salmirs executed an insider sale, selling 10,424 shares of ABM Industries (NYSE) for approximately $486,600.00 following a stock price surge. The transaction occurred after ABM
Technology, Media, and Leveraged ETF Moves Drive Today’s Top Gainers Technology, media, and high-volatility small-cap stocks led several of today’s strongest market moves. Company-specific developments, including Nasdaq compliance news and acquisition speculation, fue
Market Downturn: Horizon Space Acquisition II, Astrotech, Momentus, Destiny Tech100, and SATG Face Significant Losses A completed SPAC business combination triggered major volatility in Horizon Space Acquisition II Corp. Several high-volatility small-cap stocks and space-related
Intel Corporation (NASDAQ:INTC) received "Positive" and "Buy" upgrades from major financial firms, signaling strong analyst confidence in the semiconductor giant. Intel's shares surged 8% following the upgrades, reaching nearly $127 , with high trading volume indicating robust in
Aeries Technology (NASDAQ: AERT) Executes Reverse Stock Split Amid Financial Turnaround Aeries Technology (NASDAQ: AERT) implemented a 1-for-8 reverse share split , consolidating its Class A ordinary shares and increasing its per-share price on a split-adjusted basis. The move co
Netflix (NASDAQ: NFLX) exhibits mixed stock performance despite robust subscriber growth and strong financial health. Citigroup (NYSE: C) has adjusted its analyst rating on Netflix to "Hold" amid evolving market conditions. While ad-supported plans and Q1 2026 financials demonstr
Key Insights: Despite a lowered price target from Truist Financial, National Health Investors (NYSE:NHI) still shows a potential upside of 12.78% from its stock price at the time of the report. Analyst sentiment is mixed, with a Zacks Rank of #4 (Sell) contrasting with a "buy" ra
SpaceX (NASDAQ: SPCX) IPO: High Valuation Meets Analyst Caution SpaceX (NASDAQ: SPCX) made a historic public-market debut after raising $75.00 billion in the largest IPO on record. The stock surged on its first day of trading, pushing the company’s valuation above $2.00 tri
Anixa Biosciences (NASDAQ:ANIX) is showcasing significant pipeline progress with presentations on its ovarian cancer therapy, lira-cel, and a breast cancer vaccine. Leading analyst firms H.C. Wainwright and Citigroup have reiterated "Buy" ratings for Anixa Biosciences, signaling
Analyst firm Barrington increased its price target for Dave Inc. (NASDAQ: DAVE) to $310 , representing a potential upside of 7.89% from its previous stock price. The digital banking application reported robust first-quarter financial results, with revenue climbing 47% year-over-y
Director Robert W. Duggan invested $50.00 million in Summit Therapeutics (NASDAQ:SMMT) shares, signaling strong insider confidence. The company plans a $500.00 million public offering to fund the development of its promising lung cancer drug, ivonescimab. Analysts project a signi
Truist Financial (NYSE:TFC) recently increased its price target for Six Flags Entertainment Corporation (NYSE:FUN) , signaling a potential 15.77% upside for the stock. The company is driving future growth through new attractions like the Werewolf Gorge roller coaster and an expan
Analyst Ivan Feinseth of Tigress Financial has increased the price target for Uber Technologies to $115 , indicating a significant potential upside for the stock. Wall Street analysts show strong confidence in Uber's future, with over 80% issuing positive recommendations. Uber de
Headlines provided by Investing.com